Tag: Arbor Pharmaceuticals

All

RLS Foundation Study: Restless Legs Syndrome Takes High Toll on Health

In ODYSSEY II, 2,745 people with confirmed RLS completed a survey about RLS diagnosis and severity, associated medical conditions, treatments, and medical care.

Don’t Light the Fuse of Restless Legs Syndrome with Dopamine Agonists
Azurity Pharmaceuticals Acquires Arbor Pharmaceuticals
Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?
FDA Warns of Serious Breathing Problems with Gabapentinoids When Used with CNS Depressants or in Patients with Lung Problems
What New Research Suggests About Psychiatric Adverse Events and Popular Restless Legs Syndrome Drugs
Beacon of Hope for RLS Sufferers: J. Steven Poceta, MD

All

Sorry, No Posts Found

All

Sorry, No Posts Found

Sorry, No Posts Found